Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy combined with temozolomide for newly diagnosed primary central nervous system lymphoma
ChiCTR-OPC-14005409Phase 2Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Oct 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in primary central nervous system lymphoma (PCNSL), sponsored by The First Hospital of Jilin University. Primary endpoints: Objective remission rate and Toxic reaction. Started Oct 2014; status: recruiting.
02
Drugs
temozolomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on ChiCTR-OPC-14005409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-14005409.